Blinatumomab approved as consolidation therapy for MRD-negative B-cell precursor acute lymphoblastic leukemia. Nierengarten MB. Cancer 2024;130:3622.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Nierengarten MB. Blinatumomab approved as consolidation therapy for MRD-negative B-cell precursor acute lymphoblastic leukemia. Cancer 2024;130:3622.
PMID: 39382254